634 related articles for article (PubMed ID: 31103483)
1. Current Strategies in the Management of Peyronie's Disease (PD)-Results of a Survey of 401 Sexual Medicine Experts Across Europe.
Porst H; Burri A;
J Sex Med; 2019 Jun; 16(6):901-908. PubMed ID: 31103483
[TBL] [Abstract][Full Text] [Related]
2. A Worldwide Survey on Peyronie's Disease Surgical Practice Patterns Among Surgeons.
Chung E; Wang R; Ralph D; Levine L; Brock G
J Sex Med; 2018 Apr; 15(4):568-575. PubMed ID: 29550462
[TBL] [Abstract][Full Text] [Related]
3. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Sukumar S; Pijush DB; Brandes S
J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
[TBL] [Abstract][Full Text] [Related]
5. Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation.
Manka MG; White LA; Yafi FA; Mulhall JP; Levine LA; Ziegelmann MJ
J Sex Med; 2021 Feb; 18(2):363-375. PubMed ID: 33423972
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
7. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
[TBL] [Abstract][Full Text] [Related]
8. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
9. Real-world practice in Peyronie's disease management: Results from a national survey of urologists.
Brant A; Basourakos SP; Lewicki P; Kang C; Marinaro J; Punjani N; Kashanian JA
Andrology; 2023 Oct; 11(7):1320-1325. PubMed ID: 36815582
[TBL] [Abstract][Full Text] [Related]
10. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
12. Urologist practice patterns in the management of Peyronie's disease: a nationwide survey.
Shindel AW; Bullock TL; Brandes S
J Sex Med; 2008 Apr; 5(4):954-964. PubMed ID: 18042214
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
14. Peyronie's disease.
Pryor J; Akkus E; Alter G; Jordan G; Lebret T; Levine L; Mulhall J; Perovic S; Ralph D; Stackl W
J Sex Med; 2004 Jul; 1(1):110-5. PubMed ID: 16422991
[TBL] [Abstract][Full Text] [Related]
15. Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations from the European Society of Sexual Medicine (ESSM).
Capogrosso P; Frey A; Jensen CFS; Rastrelli G; Russo GI; Torremade J; Albersen M; Gruenwald I; Reisman Y; Corona G
J Sex Med; 2019 Oct; 16(10):1490-1505. PubMed ID: 31447380
[TBL] [Abstract][Full Text] [Related]
16. Review of Management Options for Patients With Atypical Peyronie's Disease.
Yafi FA; Hatzichristodoulou G; DeLay KJ; Hellstrom WJ
Sex Med Rev; 2017 Apr; 5(2):211-221. PubMed ID: 27544298
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of RestoreX Penile Traction Therapy in Men With Peyronie's Disease: Results From Open Label and Follow-up Phases.
Joseph J; Ziegelmann MJ; Alom M; Savage J; Köhler TS; Trost L
J Sex Med; 2020 Dec; 17(12):2462-2471. PubMed ID: 33223425
[TBL] [Abstract][Full Text] [Related]
19. Review of Management Options for Active-Phase Peyronie's Disease.
Brimley SC; Yafi FA; Greenberg J; Hellstrom WJG; Tue Nguyen HM; Hatzichristodoulou G
Sex Med Rev; 2019 Apr; 7(2):329-337. PubMed ID: 30503796
[TBL] [Abstract][Full Text] [Related]
20. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
El-Khatib FM; Towe M; Yafi FA
World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
